Page Nav

HIDE

Grid

GRID_STYLE

Trending News

latest

Namibia Fights Against Antimicrobial Resistance

The emergence of drug-resistant bacteria in Namibia poses a serious risk to the well-being of the population /Photo file. Antimicrobial resi...

The emergence of drug-resistant bacteria in Namibia poses a serious risk to the well-being of the population /Photo file.
Antimicrobial resistance (AMR) is a global health threat that is of particular concern in African countries like Namibia, where access to healthcare resources may be limited. In recent years, Namibia has taken steps to address the issue of Antimicrobial resistance, but more work is needed to ensure that antibiotics remain effective in the long run.

The global health concern has caught the attention of the Ministry of Health and Social Services (MOHSS). The MOHSS has recognized that the emergence of drug-resistant bacteria is a major public health threat that can lead to increased morbidity and mortality, increased healthcare costs, and prolonged hospital stays.

To address this issue, the MOHSS has developed a National Action Plan on Antimicrobial Resistance (NAP-AMR), which is a comprehensive strategy to prevent the emergence and spread of AMR in Namibia. The NAP-AMR was launched in 2017 and outlines a series of actions and interventions to be implemented across different sectors.

The MOHSS plays a key role in the implementation of the NAP-AMR, particularly in the healthcare sector. Some of the key actions that the MOHSS is responsible for include:

  • Promoting the appropriate use of antibiotics through the development of antibiotic stewardship programs in healthcare facilities.
  • Strengthening surveillance systems to detect and monitor cases of AMR in Namibia.
  • Raising awareness among healthcare providers, patients, and the public about the appropriate use of antibiotics and the risks associated with AMR.
  • Strengthening laboratory capacity to improve the diagnosis and management of infectious diseases.
  • Investing in research and development to identify new treatments for infectious diseases and alternative strategies to prevent and control AMR.

The Ministry of Health and Social Services recognizes the importance of addressing AMR in Namibia and is committed to implementing the NAP-AMR in far remote areas to prevent the emergence and spread of drug-resistant bacteria. One of the primary drivers of drug-resistant bacteria in Namibia is the overuse and misuse of antibiotic drugs.

In some cases, antibiotics are prescribed unnecessarily or inappropriately, or obtained through illicit means leading to the emergence of resistant strains of bacteria in the country. Additionally, poor hygiene and sanitation practices in Namibia especially in urban informal settlements can contribute to the spread of resistant bacteria, further fueling the problem in the country.

To address this issue, the Namibian government has developed a National Action Plan on Antimicrobial Resistance, which includes a range of interventions to improve antibiotic stewardship, strengthen surveillance and monitoring health systems, and raise public awareness of the issue. The plan also includes measures to improve infection prevention and control in healthcare facilities, as well as efforts to promote the appropriate use of antibiotics in both human and animal health.

Namibia is also a signatory to the Global Action Plan on Antimicrobial Resistance, which was developed by the World Health Organization (WHO) in response to the growing threat of AMR. The plan calls for coordinated action across sectors to improve the use of antibiotics and promote the development of new treatments.

In addition to these efforts, Namibia is also working to improve its laboratory capacity to better detect and monitor cases of AMR. This includes investing in new medical technologies and equipment, as well as training laboratory staff on best practices for antimicrobial susceptibility testing.

Despite these efforts, more work is needed to address the issue of AMR in Namibia and other low- and middle-income countries. This includes strengthening healthcare systems, improving access to healthcare resources, and increasing public awareness of the issue. With coordinated action and ongoing investment, it is possible to reduce the impact of AMR and ensure that antibiotics remain effective for generations to come.

There are many antibiotic drugs used to treat bacterial infections in Namibia, just like in other countries. These drugs work by either killing the bacteria or stopping their growth, and they have been instrumental in reducing the burden of infectious diseases in Namibia and improving overall health outcomes.

Below are some of the drugs available in Namibia that are constantly updated due to new drug approvals, withdrawals, and market availability changes include:

  • Antibiotics, such as Amoxicillin, Ciprofloxacin, Doxycycline, and Azithromycin, used to treat infections
  • Antiretroviral drugs, such as Tenofovir, Emtricitabine, and Efavirenz, are used to treat HIV/AIDS
  • Antimalarial drugs, such as Artemether-lumefantrine, used to treat malaria
  • Analgesics, such as paracetamol and Ibuprofen, used to treat pain and fever
  • Antihypertensive drugs, such as Lisinopril, used to lower blood pressure
  • Antidiabetic drugs, such as Metformin and Insulin, used to treat diabetes
  • Antipsychotic drugs, such as haloperidol and risperidone, used to treat mental health disorders

It is important to note that these drugs should only be used under the guidance of a licensed healthcare provider and in accordance with their prescribing instructions to ensure their appropriate use and prevent misuse or abuse. Antibiotics are commonly used to treat a range of infections, including respiratory tract infections, skin infections, urinary tract infections, and sexually transmitted infections. They are also used to prevent infections in some cases, such as before and after surgery, or for people with weakened immune systems.

However, the overuse and misuse of antibiotics in Namibia and other countries have led to the emergence of antibiotic-resistant bacteria, which are harder to treat and can cause serious health complications. This has become a growing concern in Namibia, as well as globally, as it threatens the effectiveness of antibiotics and could lead to a future where many infections become untreatable as you can see in the diagram below, how the drugs are being rendered inoperable.


To address this issue, the Namibian government has developed a National Action Plan on Antimicrobial Resistance, which includes measures to improve antibiotic stewardship and promote the appropriate use of antibiotics in both human and animal health. This plan also emphasizes the importance of strengthening surveillance and monitoring systems to detect and respond to cases of antibiotic resistance, as well as investing in research and development to identify new treatments for infectious diseases.

The National Action Plan on Antimicrobial Resistance is a comprehensive plan developed by several countries to address the growing threat of antimicrobial resistance (AMR). The plan includes a range of interventions designed to promote the responsible use of antibiotics, improve infection prevention and control, and strengthen surveillance and monitoring systems to detect and respond to cases of AMR.

Some of the key components of a National Action Plan on AMR may include:

  1. Improving antibiotic stewardship: This involves promoting the appropriate use of antibiotics in both human and animal health, including measures to reduce the overuse and misuse of antibiotics.
  2. Strengthening infection prevention and control: This includes improving hygiene and sanitation practices, implementing appropriate infection prevention measures in healthcare facilities, and promoting the appropriate use of personal protective equipment.
  3. Enhancing surveillance and monitoring systems: This involves strengthening laboratory capacity to detect and monitor cases of AMR, improving data collection and analysis systems, and promoting collaboration between different sectors to share information and resources.
  4. Increasing public awareness: This includes raising public awareness of the risks associated with AMR, promoting the appropriate use of antibiotics, and educating the public about ways to prevent the spread of resistant infections.
  5. Promoting research and development: This includes investing in the development of new antibiotics and alternative treatments for infectious diseases, as well as supporting research into the drivers of AMR and ways to address the issue.

Overall, while antibiotics remain an important tool in treating bacterial infections in Namibia, there is a need for ongoing efforts to promote their appropriate use and prevent the emergence and spread of antibiotic-resistant bacteria in the country.

In Namibia, drugs are regulated by the Namibia Medicines Regulatory Council (NMRC), which is responsible for ensuring the safety, efficacy, and quality of medicines available in the country. The NMRC is also responsible for approving and registering medicines, as well as monitoring their use to ensure they are used appropriately.

There are various types of drugs available in Namibia, including prescription drugs, over-the-counter drugs, and traditional medicines. Prescription drugs require a prescription from a licensed healthcare provider, while over-the-counter drugs can be purchased without a prescription but still require responsible use. Traditional medicines, which are often derived from natural sources, are also commonly used in Namibia and are regulated by the Traditional Health Practitioners Council.

The availability and accessibility of drugs in Namibia can be challenging, particularly in rural and remote areas. There are ongoing efforts to improve access to essential medicines, including through the implementation of the National Medicine Policy and the Essential Medicines List, which aim to ensure that essential medicines are available and accessible to all Namibians.


This article has been written and compiled by Nambili Samuel, a biophysicist currently residing and studying in Turkey. With expertise in the medical field, Nambili has a keen interest in healthcare and the impact of scientific developments on society. Through his writing, he aims to raise awareness and provide insights into various health-related topics, including antimicrobial resistance, infectious diseases, and drug discovery. Nambili served as a medical officer in the Ministry of Defence before moved to overseas. He is also actively involved in research, having published several papers in peer-reviewed journals. His research interests include the study of molecular dynamics, bioinformatics, artificial intelligence, and drug design. Nambili's international background, having lived and studied in different countries, has given him a unique perspective on global health issues. He leverages his diverse experiences and expertise to provide valuable insights into Namibian healthcare-related matters.